Pramirol SR 1.05 Tablet
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Pramipexole (1.05mg)
Overview Pramirol SR 1.05 Tablet
Pramipexole extended-release 1.05 mg tablets manage Parkinson's disease symptoms and restless legs syndrome, characterized by an irresistible urge to move legs often due to unpleasant sensations. This medication reduces excessive tremor by moderating body movements. Administer Pramipexole ER 1.05 mg with food, consistently at the same time daily for stable blood levels. Follow your physician's prescribed dosage and duration; if a dose is missed, take it immediately upon recall. Complete the full course of treatment, even with symptom improvement; never abruptly discontinue use without consulting your doctor. Potential side effects include nausea, dry mouth, tiredness, visual disturbances, constipation, and swelling in the extremities. Drowsiness and dizziness are possible; avoid driving or tasks requiring alertness until the drug's effects are known. Report any unusual shifts in mood, hypersexuality, compulsive gambling, or excessive spending to your doctor promptly, as these can be serious.
Uses of Pramirol SR 1.05 Tablet
Tremors and involuntary movements | Uncontrollable leg urges
Major Benefits of Pramirol SR 1.05 Tablet:
Follow your physician's instructions or refer to the product label for usage guidance. Administer Pramirol SR 1.05 Tablet with food.
Common Side effects of Pramirol SR 1.05 Tablet:
- Dizziness
- Sleepiness
- Nausea
- Dryness in mouth
- Fatigue
- Hallucination
- Constipation
- Peripheral edema
- Muscle spasm
How to use Pramirol SR 1.05 Tablet:
Follow your doctor's instructions or consult the product labeling for guidance prior to administration. Ingest Pramirol SR 1.05 Tablet with a meal.
How Pramirol SR 1.05 Tablet works:
Pramirol SR 1.05 mg tablets function by replicating the effects of dopamine, a neurotransmitter crucial for regulating motor control within the brain.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Pramirol SR 1.05 mg tablets and alcohol can lead to increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
The use of Pramirol SR 1.05 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Using Pramirol SR 1.05 Tablet while breastfeeding is likely inadvisable. Studies in humans indicate potential transfer to breast milk, posing a risk to the infant. This medication's prolactin-suppressing effect could negatively impact lactation.
DrivingUNSAFE
Driving ability may be impaired by Pramirol SR 1.05 Tablet side effects, including hallucinations – experiencing sensations or perceptions without external stimuli.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Pramirol SR 1.05 mg tablets, as dose modification may be necessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
Pramirol SR 1.05 Tablets appear to pose minimal risk for individuals with hepatic impairment. Existing evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Pramirol SR 1.05 Tablet :
Omit any missed Pramirol SR 1.05 Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Pramirol SR 1.05 Tablet
| Label | Value |
|---|---|
| Chemical Category | Benzothiazole-based compound |
| Developing Habits | No. |
| Treatment Category | Neuroscience Central Nervous System |
| Actions | Dopamine-stimulating medications |






